Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep. 2022 Feb 7;12(1):2003. doi: 10.1038/s41598-022-05736-4.
The present article describes the design, synthesis, in vitro urease inhibition, and in silico molecular docking studies of a novel series of nitrothiazolacetamide conjugated to different thioquinazolinones. Fourteen nitrothiazolacetamide bearing thioquinazolinones derivatives (8a-n) were synthesized through the reaction of isatoic anhydride with different amine, followed by reaction with carbon disulfide and KOH in ethanol. The intermediates were then converted into final products by treating them with 2-chloro-N-(5-nitrothiazol-2-yl)acetamide in DMF. All derivatives were then characterized through different spectroscopic techniques (H, C-NMR, MS, and FTIR). In vitro screening of these molecules against urease demonstrated the potent urease inhibitory potential of derivatives with IC values ranging between 2.22 ± 0.09 and 8.43 ± 0.61 μM when compared with the standard thiourea (IC = 22.50 ± 0.44 μM). Compound 8h as the most potent derivative exhibited an uncompetitive inhibition pattern against urease in the kinetic study. The high anti-ureolytic activity of 8h was confirmed against two urease-positive microorganisms. According to molecular docking study, 8h exhibited several hydrophobic interactions with Lys10, Leu11, Met44, Ala47, Ala85, Phe87, and Pro88 residues plus two hydrogen bound interactions with Thr86. According to the in silico assessment, the ADME-Toxicity and drug-likeness profile of synthesized compounds were in the acceptable range.
本文描述了一系列新型硝基噻唑乙酰胺与不同硫代喹唑啉酮的连接物的设计、合成、体外脲酶抑制作用以及计算机分子对接研究。通过异丁酰苯并呋喃与不同胺的反应,然后与二硫化碳和 KOH 在乙醇中反应,合成了 14 种含有硫代喹唑啉酮的硝基噻唑乙酰胺衍生物(8a-n)。中间体然后通过在 DMF 中与 2-氯-N-(5-硝基噻唑-2-基)乙酰胺反应转化为最终产物。所有衍生物均通过不同的光谱技术(H、C-NMR、MS 和 FTIR)进行了表征。这些分子对脲酶的体外筛选表明,与标准硫脲(IC=22.50±0.44μM)相比,衍生物具有 2.22±0.09-8.43±0.61μM 的潜在脲酶抑制活性。作为最有效衍生物的 8h 在动力学研究中表现出对脲酶的非竞争性抑制模式。8h 对两种脲酶阳性微生物的抗解脲活性得到了证实。根据分子对接研究,8h 与 Lys10、Leu11、Met44、Ala47、Ala85、Phe87 和 Pro88 残基之间表现出几种疏水相互作用,并与 Thr86 之间存在两个氢键相互作用。根据计算机评估,合成化合物的 ADME-毒性和类药性特征在可接受范围内。